Largest Clinical Trials companies in Australia by Market Capitalization
Australia
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 5.17 B |
Jan. 14, 2025 | USD 15.47 | 4.25% |
|
Australia |
|
| 2 |
USD 754.75 M |
Jan. 14, 2025 | USD 2.37 | 1.84% |
|
Australia |
|
| 3 |
USD 425.31 M |
Jan. 14, 2025 | USD 2.14 | 0.82% |
|
Australia |
|
| 4 |
USD 28.94 M |
Jan. 14, 2025 | USD 3.31 | -4.06% |
|
Australia |
Frequently Asked Questions
-
Which Clinical Trials company in Australia has the highest Market Capitalization ?
The Clinical Trials company in Australia with the highest Market Capitalization is Telix Pharmaceuticals Limited (ASX: TLX.AX) at USD 5.17 B.
-
Which Clinical Trials company in Australia has the lowest Market Capitalization ?
The Clinical Trials company in Australia with the lowest Market Capitalization is Alterity Therapeutics Limited (NasdaqCM: ATHE) at USD 28.94 M.
-
What are the top 10 Clinical Trials companies in Australia by Market Capitalization ?
The top 10 Clinical Trials companies in Australia by Market Capitalization are Telix Pharmaceuticals Limited, Clarity Pharmaceuticals Ltd, Australian Clinical Labs Limited and Alterity Therapeutics Limited.
-
What are the bottom 10 Clinical Trials companies in Australia by Market Capitalization ?
The bottom 10 Clinical Trials companies in Australia by Market Capitalization are Alterity Therapeutics Limited, Australian Clinical Labs Limited, Clarity Pharmaceuticals Ltd and Telix Pharmaceuticals Limited.